NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 171452 | BGB-15025 | 2766481-17-6 | ≧98.0% |  |
| BGB-15025 is a potent and selective HPK1 inhibitor that is efficacious as a single ag | ||||
| 18576 | VU0467154 | 1451993-15-9 | ≧98.0% |  |
| VU0467154 is a positive allosteric modulator of theM4 muscarinic acetylcholine recept | ||||
| 121431 | KW-2478 | 819812-04-9 | 98% |  |
| KW-2478 is an agent that targets the human heat-shock protein 90 (Hsp90) with potenti | ||||
| 20509 | GLPG3667 | 2308520-97-8 | ≧98.0% |  |
| GLPG3667 is an oral potent and selective small-molecule TYK2 inhibitor in development | ||||
| 181121 | AZD-5904 | 618913-30-7 | ≧98.0% |  |
| AZD5904 is a potent orally bioavailable MPO inhibitor. In preclinical studies, AZD590 | ||||
| 41788 | CB-6644 | 2316817-88-4 | 96.33% |  |
| CB-6644 acts as a noncompetitive ATPase inhibitor. Additionally, it can inhibit RUVBL | ||||
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | _1792180-81-4.png) |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 20449 | Ervogastat (PF-06865571) | 2186700-33-2 | ≧98.0% |  |
| Ervogastat (PF-06865571), a systemically acting diacylglycerol acyltransferase (DGAT2 | ||||
| 171680 | Bexotegrast ( PLN-74809 ) | 2376257-44-0 | ≧98.0% | .png) |
| Bexotegrast (Synonyms: PLN-74809) is a small-molecule, dual selective inhibitor of α | ||||
| 237072 | AZD0095 | 2750001-23-9 | ≧98.0% |  |
| AZD0095 is a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. | ||||
| 20642 | OATD-02 | 2146132-73-0 | ≧98.0% |  |
| OATD-02, an orally available dual arginase inhibitor (ARG1 and ARG2), is in phase I c | ||||
| 20641 | KP-302 ( Synonyms: Lucid-21-302 ; Lucid-MS ) | 2082765-42-0 | ≧98.0% | _2082765-42-0.png) |
| KP-302 ( Synonyms: Lucid-21-302 ; Lucid-MS ) is a small molecule inhibitor of protein | ||||